======= AGAP2 ======= == Gene Information == * **Official Symbol**: AGAP2 * **Official Name**: ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=116986|116986]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q99490|Q99490]] * **Interactions**: [[https://thebiogrid.org/search.php?search=AGAP2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20AGAP2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/605476|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene belongs to the centaurin gamma-like family. It mediates anti-apoptotic effects of nerve growth factor by activating nuclear phosphoinositide 3-kinase. It is overexpressed in cancer cells, and promotes cancer cell invasion. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Aug 2011]. * **UniProt Summary**: GTPase-activating protein (GAP) for ARF1 and ARF5, which also shows strong GTPase activity. Isoform 1 participates in the prevention of neuronal apoptosis by enhancing PI3 kinase activity. It aids the coupling of metabotropic glutamate receptor 1 (GRM1) to cytoplasmic PI3 kinase by interacting with Homer scaffolding proteins, and also seems to mediate anti-apoptotic effects of NGF by activating nuclear PI3 kinase. Isoform 2 does not stimulate PI3 kinase but may protect cells from apoptosis by stimulating Akt. It also regulates the adapter protein 1 (AP-1)-dependent trafficking of proteins in the endosomal system. It seems to be oncogenic. It is overexpressed in cancer cells, prevents apoptosis and promotes cancer cell invasion. {ECO:0000269|PubMed:12640130, ECO:0000269|PubMed:14761976, ECO:0000269|PubMed:15118108, ECO:0000269|PubMed:16079295}. |ArfGap| |Miro| |Ank 2| |PH| |Ras| |regulation of 1-phosphatidylinositol-3-kinase activity| |positive regulation of 1-phosphatidylinositol-3-kinase activity| |positive regulation of phosphatidylinositol biosynthetic process| |regulation of phosphatidylinositol biosynthetic process| |positive regulation of phospholipid biosynthetic process| |regulation of phospholipid biosynthetic process| |positive regulation of phosphatidylinositol 3-kinase activity| |positive regulation of lipid kinase activity| |positive regulation of phospholipid metabolic process| |regulation of phosphatidylinositol 3-kinase activity| |regulation of lipid kinase activity| |positive regulation of lipid biosynthetic process| |regulation of phospholipid metabolic process| |negative regulation of protein catabolic process| |positive regulation of lipid metabolic process| |negative regulation of neuron apoptotic process| |regulation of lipid biosynthetic process| |negative regulation of neuron death| |regulation of neuron apoptotic process| |GTPase activator activity| |negative regulation of catabolic process| |regulation of neuron death| |GTPase activity| |regulation of protein catabolic process| |GTP binding| |regulation of lipid metabolic process| |positive regulation of GTPase activity| |regulation of GTPase activity| |positive regulation of kinase activity| |positive regulation of transferase activity| |positive regulation of hydrolase activity| |nucleolus| |regulation of kinase activity| |negative regulation of apoptotic process| |negative regulation of programmed cell death| |regulation of transferase activity| |regulation of catabolic process| |negative regulation of cell death| |positive regulation of phosphorylation| |negative regulation of protein metabolic process| |positive regulation of phosphate metabolic process| |positive regulation of phosphorus metabolic process| |mitochondrion| |regulation of hydrolase activity| |positive regulation of catalytic activity| |protein transport| |peptide transport| |regulation of apoptotic process| |regulation of programmed cell death| |amide transport| |regulation of phosphorylation| |establishment of protein localization| |regulation of cell death| |positive regulation of molecular function| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |nitrogen compound transport| |positive regulation of cellular biosynthetic process| |membrane| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp331|A-769662 20μM R07 exp331]]|1.71| |[[:results:exp319|ABT-702 5μM plus Dimethyloxaloylglycine 11μM R07 exp319]]|1.8| |[[:results:exp340|BN82002 4μM R07 exp340]]|1.81| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 3224 * **Expression level (log2 read counts)**: 4.37 {{:chemogenomics:nalm6 dist.png?nolink |}}